A61K 38/168
From plants
Official title: {from plants}
A61K38/168 (From plants) appears on 446 US grants and 778 published applications in this corpus.
Search patents in A61K- Granted patents
- 446
- Published applications
- 778
- Assignees
- 437
- Inventors
- 1,331
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 7 | 0 |
| 1997 | 9 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 10 | 0 |
| 2001 | 5 | 3 |
| 2002 | 6 | 8 |
| 2003 | 9 | 24 |
| 2004 | 6 | 20 |
| 2005 | 4 | 19 |
| 2006 | 12 | 21 |
| 2007 | 8 | 17 |
| 2008 | 7 | 16 |
| 2009 | 10 | 17 |
| 2010 | 14 | 20 |
| 2011 | 10 | 23 |
| 2012 | 17 | 32 |
| 2013 | 8 | 25 |
| 2014 | 18 | 38 |
| 2015 | 23 | 42 |
| 2016 | 30 | 82 |
| 2017 | 27 | 45 |
| 2018 | 33 | 46 |
| 2019 | 27 | 59 |
| 2020 | 28 | 35 |
| 2021 | 24 | 27 |
| 2022 | 15 | 38 |
| 2023 | 10 | 28 |
| 2024 | 15 | 39 |
| 2025 | 15 | 32 |
| 2026 | 12 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-viral compositions and methods of making and using6 Oct 2026US 12,753,211 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Herbal composition for cancer25 Aug 2026US 12,714,735 B2
- Prebiotic compositions and method for promoting growth of Hafnia alvei by using the same28 Jul 2026US 12,691,156 B2Tcico., Ltd.
- Compositions and methods for digestive health in an feline19 May 2026US 12,629,403 B2Societe des Produits Nestle S. A.
- Fusion proteins and uses thereof28 Apr 2026US 12,611,440 B2Synklino A/S
- A proimmunotoxin therapeutic nanoplatform against cancer8 Oct 2026US 2026/0308268 A1The Regents of the University of California
- Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns1 Oct 2026US 2026/0297191 A1ImmunoBrain Checkpoint, Inc.
- Method of using bioactive peptide fraction isolated from canary seed24 Sep 2026US 2026/0284143 A1Purdue Research Foundation
- Glycan-dependent Immunotherapeutic Molecules10 Sep 2026US 2026/0263619 A1The Regents of the University of California
- Compositions and methods for digestive health in a feline3 Sep 2026US 2026/0256861 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Enhancement of antimicrobial peptide activity by metal ions108US 6,042,848 ABoard of Trustees of Southern Illinois University · 2000
- Systems and methods for delivery of a therapeutic agent105US 7,608,275 B2The Foundry, LLC · 2009
- Methods of normalizing metabolic parameters in diabetics101US 5,468,727 ABoard of Regents, The University of Texas System · 1995
- Prophylaxis against diseases tramsmittable by sexual contact, and therapy of such diseases99US 5,840,771 ALegere Pharmaceuticals, Ltd. · 1998
- Injectable embolization and occlusion solution91US 4,268,495 AEthicon, Inc. · 1981